Prognostic impact of RAS mutation on papillary thyroid carcinoma: a systematic review and meta-analysis

Alireza Abdollahi, Seyed Morteza Pourfaraji, Fatemeh Ojaghi Shirmard, Reza Ghalehtaki, Samaneh Salarvand · 2025

Read Prognostic impact of RAS mutation on papillary thyroid carcinoma: a systematic review and meta-analysis by Alireza Abdollahi, Seyed Morteza Pourfaraji, Fatemeh Ojaghi Shirmard, Reza Ghalehtaki, Samaneh Salarvand (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12713272.txt.

Description

Alireza Abdollahi, Seyed Morteza Pourfaraji, Fatemeh Ojaghi Shirmard, Reza Ghalehtaki, and Samaneh Salarvand pool studies on a gene family's role in thyroid cancer in a paper from 2025. RAS mutations appear in about a fifth of papillary thyroid cancers. The meta-analysis covered twenty-two studies and over four thousand seven hundred patients. Outcomes included spread, recurrence, death, and tumor size. Mutations tripled the odds of distant spread.

No clear links emerged for recurrence-free survival, overall death, recurrence, or tumor size. The authors suggest mutation testing after surgery to flag patients needing closer watch. Personal treatment plans could follow from that risk sorting. They note the evidence base is still uneven across outcomes.

Catalog record

CREATORAlireza Abdollahi, Seyed Morteza Pourfaraji, Fatemeh Ojaghi Shirmard, Reza Ghalehtaki, Samaneh Salarvand
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE22 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12713272

Browse the full library · About the Tower of Babel